AMIN SHAHRBAF, M.; SAMIMI, M.; KARIMI, S.; SALARI, M.; GHAFFARI, M.; YAZDANBAKHSH, S.; NAJAFIAN, A.; VOSOUGH, M.; MASSOOD NABAVI, S. The first study of real-world efficacy and safety of Natalizumab (Tysabri®) in Iran. Trends in Immunotherapy, [S. l.], v. 8, n. 1, 2024. DOI: 10.24294/ti.v8.i1.3920. Disponível em: https://ojs.ukscip.com/index.php/ti/article/view/476. Acesso em: 3 apr. 2025.